Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AZTR
stocks logo

AZTR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-0.370
-82.3%
--
--
-1.020
-33.41%
--
--
-0.710
-40.77%
Estimates Revision
Stock Price
Go Down
down Image
-57.38%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Azitra Inc (AZTR.A) is -0.27, compared to its 5-year average forward P/E of -2.73. For a more detailed relative valuation and DCF analysis to assess Azitra Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.73
Current PE
-0.27
Overvalued PE
2.98
Undervalued PE
-8.44

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
185.41
Current PS
0.00
Overvalued PS
736.57
Undervalued PS
-365.74
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

AZTR News & Events

Events Timeline

(ET)
2025-11-24
09:15:40
Azitra sets private placement of 4.69 million shares at $0.32 each
select
2025-11-07 (ET)
2025-11-07
06:09:00
Azitra denies claims of $44M registered direct offering in report.
select
2025-10-20 (ET)
2025-10-20
08:08:07
Azitra to Showcase Preclinical Advancements in Its ATR-01 Program
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-13Yahoo Finance
Azitra, Inc. Reports Q3 2025 Financial Results and Shares Business Developments

  • Q3 2025 Business Highlights: Azitra, Inc. reported significant progress in its clinical programs, including the initiation of a Phase 1/2 trial for ATR-04 targeting EGFRi-associated rash and positive preclinical data for ATR-01 aimed at ichthyosis vulgaris.

  • Financial Performance: The company reported a net loss of $2.8 million for Q3 2025, an increase from $1.0 million in the same period in 2024, with cash and cash equivalents at $1.4 million as of September 30, 2025.

  • Focus on Rare Skin Diseases: Azitra's lead program, ATR-12, targets Netherton syndrome, a severe skin condition with no approved treatments, highlighting the company's commitment to addressing unmet medical needs in dermatology.

  • Future Outlook: The company remains optimistic about the potential of its three development programs (ATR-12, ATR-04, and ATR-01) and continues to leverage its proprietary platform for engineered proteins and topical live biotherapeutic products.

[object Object]
Preview
7.0
10-04SeekingAlpha
Azitra Notified of Non-Compliance by NYSE American

  • Compliance Notice: Azitra received a notice from NYSE American for not meeting continued listing standards due to insufficient stockholders' equity, with reported losses in three of the last four fiscal years.

  • Action Plan and Funding: The company has until October 31, 2025, to submit a plan to regain compliance by April 1, 2027, and is exploring multiple funding options; the notice does not affect trading or operations.

[object Object]
Preview
4.5
08-28Benzinga
Crude Oil Rises More Than 1%; UP Fintech Stock Takes a Dive

  • U.S. Stock Market Performance: U.S. stocks saw gains with the Dow Jones increasing by over 150 points, closing at 45,599.62, while the NASDAQ and S&P 500 also rose slightly.

  • Sector Movements: Energy shares increased by 0.7%, whereas materials stocks experienced a minor decline of 0.1%.

  • Notable Company Performances: MongoDB's shares surged 32% after positive financial results, NovaBay Pharmaceuticals jumped 85% due to a special cash dividend announcement, while UP Fintech and Kindly MD saw significant declines in their stock prices.

  • Global Market Trends: European shares were mixed, with the eurozone's STOXX 600 falling slightly, while Asian markets closed mixed as well, with Japan's Nikkei gaining and China's Shanghai Composite declining.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Azitra Inc (AZTR) stock price today?

The current price of AZTR is 0.366 USD — it has decreased -1.35 % in the last trading day.

arrow icon

What is Azitra Inc (AZTR)'s business?

Azitra, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. It has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its lead product, ATR-12, is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its advanced product, ATR-04, is a genetically modified strain of S. epidermidis for treating papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.

arrow icon

What is the price predicton of AZTR Stock?

Wall Street analysts forecast AZTR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AZTR is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Azitra Inc (AZTR)'s revenue for the last quarter?

Azitra Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

arrow icon

What is Azitra Inc (AZTR)'s earnings per share (EPS) for the last quarter?

Azitra Inc. EPS for the last quarter amounts to -0.67 USD, decreased -42.24 % YoY.

arrow icon

What changes have occurred in the market's expectations for Azitra Inc (AZTR)'s fundamentals?

The market is revising No Change the revenue expectations for AZTR for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -57.38%.
arrow icon

How many employees does Azitra Inc (AZTR). have?

Azitra Inc (AZTR) has 12 emplpoyees as of December 05 2025.

arrow icon

What is Azitra Inc (AZTR) market cap?

Today AZTR has the market capitalization of 3.74M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free